DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 5.80 0.28%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

16.81 0.29 (1.76%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SRPT $16.81 1.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.67
Previous Close $16.52
Daily Range $16.40 - $16.88
52-Week Range $14.31 - $40.00
Market Cap $694.4M
P/E Ratio -6.86
Dividend (Yield) $0.00 (0.0%)
Volume 783,174
Average Daily Volume 2,158,684
Current FY EPS -$3.19

Sector

Healthcare

Industry

Drugs

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website: http://www.sareptatherapeutics.com/

News & Commentary

BioMarin Takes Aim at Sarepta

BioMarin's acquisition of Prosensa puts it in direct competition with Sarepta.

Health Care Sector Update for 11/26/2014: SRPT,RNA,BMRN,BDX,MRGE

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Perilous Reversal Watch: Sarepta Therapeutics (SRPT)

Big News for Ebola Stocks

Sarepta Therapeutics (SRPT): Heavy Pre-Market Activity

Benzinga's Top #PreMarket Gainers

BioMarin Acquires Prosensa in Deal Valued Up to $840 Million

Celldex Therapeutics To Enter Talks With FDA

Sarepta Initiates Dosing for Study Evaluating Eteplirsen - Analyst Blog

See More SRPT News...

SRPT's Top Competitors

SRPT $16.81 (1.76%)
Current stock: SRPT
AMGN $164.72 (1.53%)
Current stock: AMGN
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB